Skip to content

R&D at other companies

Solventum logo
SolventumSOLV
$189M-2.1%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$345M+0.3%
Intuitive Surgical logo
Intuitive SurgicalISRG
$361.9M+14.5%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$103.4M-6.5%

Other financials

Income statement

See full
Revenue$1.0B+6.2%
Gross profit$736.6M+8.3%
Operating income$142.0M+8.3%
Net income$112.8M+21.0%
EPS (diluted)$1.57+23.6%

Balance sheet

See full
Cash & equivalents$1.1B+21.4%
Total debt$116.0M-2.1%
Total equity$4.1B+9.4%
Total assets$6.3B+3.5%

Cash flow

See full
Operating cash flow$151.0M+187%
CapEx$30.8M+21.7%
Free cash flow$120.3M+339%

Valuation

See full
Market cap$13.04B+4.5%
Enterprise value$12.1B+3.1%
P/E30.3×-0.1×
P/S3.2×0.0×

Profitability

See full
Gross margin67.6%-2.3pp
Operating margin13.6%-1.1pp
Net margin10.5%+0.2pp
FCF margin14.3%-1.6pp

Returns & leverage

See full
Return on equity10.8%0.0pp
Debt / equity0.0×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by Align Technology in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Align Technology’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Align Technology's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Align Technology's R&D?
Align Technology (ALGN) reported R&D of $98.66M in Q1 2026.
How has Align Technology's R&D changed year-over-year?
Align Technology's R&D increased by 1.5% year-over-year, from $97.2M to $98.66M.
What is the long-term trend for Align Technology's R&D?
Over 4 years (2021 to 2025), Align Technology's R&D has grown at a 10.3% compound annual growth rate (CAGR), from $250.32M to $369.91M.
What does R&D mean?
Spending dedicated to creating new products or improving existing technology.
How do you interpret R&D?
Higher spending often signals a commitment to future growth and innovation, while significant cuts may indicate a shift toward short-term profitability over long-term competitiveness.
How does R&D compare across companies?
Highly variable across industries; essential for tech and medical device firms but lower for mature service businesses.